No recent analyst price targets found for LABD.
Latest News for LABD

Navigate Biotech's Crosscurrents With Direxion's LABU And LABD ETFs
Although the equities market often embodies chaos and capricious non-linearity, few sectors witness as much kinetic wildness like biotechnology. At its core, biotech represents an innovative push toward addressing the human condition — which is often found to be shockingly frail.
Benzinga • Dec 18, 2025
🧮 Earnings Move Analyzer
Insider Trading
No insider trades found for LABD.
Senate Trading
No Senate trades found for LABD.
U.S. House Trading
No House trades found for LABD.
Options Chain Settings
Changes apply instantly as you toggle. Tap Done when finished.
Bid/Ask/Mark (first):
Core Metrics:
More Greeks (optional):
Valuation:
Price & Momentum:
IV Variants:
IV Units:
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.
